Chairman of the Board and CEO of BioScrip Inc. (BIOS, Financial) Richard H Friedman sells 7,861 shares of BIOS on 10/14/2009 at an average price of $7 a share.
BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors pharmaceutical manufacturers government agencies physicians and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas: specialty medication distribution and clinical management services both nationally and community-based and pharmacy benefit management services. Bioscrip Inc. has a market cap of $254.02 million; its shares were traded at around $6.9 with a P/E ratio of 19.26 and P/S ratio of 0.18.
BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors pharmaceutical manufacturers government agencies physicians and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas: specialty medication distribution and clinical management services both nationally and community-based and pharmacy benefit management services. Bioscrip Inc. has a market cap of $254.02 million; its shares were traded at around $6.9 with a P/E ratio of 19.26 and P/S ratio of 0.18.
Insiders' Positions with BIOS
- Sell:: Chairman of the Board and CEO on 10/08/2009 Richard H Friedman sold 22,139 shares of BIOS stock at the average price of 7, the price of the stock has decreased by 1.43% since
- Sell:: Chairman of the Board and CEO on 10/01/2009 Richard H Friedman sold 30,000 shares of BIOS stock at the average price of 6.63, the price of the stock has increased by 4.07% since
- Sell:: Chairman of the Board and CEO on 09/22/2009 Richard H Friedman sold 40,000 shares of BIOS stock at the average price of 7.02, the price of the stock has decreased by 1.71% since
- Sell:: Chairman of the Board and CEO on 09/04/2009 Richard H Friedman sold 39,856 shares of BIOS stock at the average price of 6.02, the price of the stock has increased by 14.62% since
- Sell:: Chairman of the Board and CEO on 09/02/2009 Richard H Friedman sold 12,400 shares of BIOS stock at the average price of 6.01, the price of the stock has increased by 14.81% since
Insiders' Positions with BIOS
- Buy:: 10% Owner on 04/30/2009 William J Nasgovitz bought 97,500 shares of BIOS stock at the average price of 3.14, the price of the stock has increased by 119.75% since
- Sell:: Vice President Mail Operations on 08/26/2009 Russel J Corvese sold 17,839 shares of BIOS stock at the average price of 6.13, the price of the stock has increased by 12.56% since
- Sell:: Executive Vice President on 08/11/2009 Scott Friedman sold 21,096 shares of BIOS stock at the average price of 5.9, the price of the stock has increased by 16.95% since
- Sell:: Executive Vice President on 08/06/2009 Scott Friedman sold 3,904 shares of BIOS stock at the average price of 6.05, the price of the stock has increased by 14.05% since
- Sell:: Executive Vice President on 08/04/2009 Barry A Posner sold 50,000 shares of BIOS stock at the average price of 6.24, the price of the stock has increased by 10.58% since
